Condition
Active Surveillance
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Not Yet Recruiting2
Recruiting2
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06914245Not ApplicableRecruiting
Personalized Care Pathways for Bowel Symptoms in Rectal Cancer Patients_contributing Factors (Treatable)
NCT07023432Phase 2Not Yet RecruitingPrimary
Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
NCT06394037Not Yet Recruiting
Active Surveillance for Limited GGNs
NCT06097910Recruiting
Surveillance for Multifocal GGNs
NCT05953181Not ApplicableActive Not Recruiting
Statistical Analysis Plan for the SANO-trial: Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active Surveillance for Oesophageal Cancer
Showing all 5 trials